Sunhee (Sunny) Lee Partner

Ms. Lee is a member of the firms Biotechnology/Pharmaceutical Group.  She has extensive experience consulting clients for their IP portfolio and writing opinions regarding patentability, infringement and freedom-to-operate.   She also has extensive experience in prosecuting patent applications.  Ms. Lee’s work focuses on biotechnology area including nucleic acid and polypeptide sequences, antibodies, pharmaceuticals, and regenerative drug areas.  Her work also covers drug delivery systems.  She also works on microfluidic device area as well as polymer materials.  She often gives lectures for researchers and industry IP managers.  She speaks fluent Korean and is a registered Korean Patent Attorney.  Ms. Lee is currently serving as vice chair of the Asia Pacific Committee of AIPPI U.S.  She also is a counsel for Korea American Intellectual Property Association. 

Virginia, District of Columbia
U.S. Patent and Trademark Office

Georgetown University Law Center (J.D.  2005;  )
Yonsei University (B.S. Biochemistry, 1985; top in the class)


Associations
International Association for the Protection of Intellectual Property  
American Intellectual Property Law Association
Licensing Executives Society
Korean American Intellectual Property Law Association (Vice President)
Korean Patent Attorney Association
Asian Patent Attorney Association
American Bar Association

Biosimilar Pathway Powerpoint Presentation

Lecture on "FDA Draft Guidances on Biosimilar Pathway" at KDRA 2012 Spring Seminar, March 23, 2012, Seoul
Lecture on "Biosimilar Pathway (Bioloogics Price Competition and Innovation Act of 2009)" at KDRA 2010 Spring Seminar, April 16, 2010, Seoul
Lecture on "Strategies in filing national stage applications in the US" at Korean Patent Attorney Association, April 15, 2010, Seoul.
Sunhee Lee and Dr. Janice Lee, “What’s Coming For Pharmaceutical Industries in 2009,” Pharmaceutical Processing, Jan. 2009

Korean Translation of “Doctrine of Equivalents in the US” written by Bruce Hamburg, published by Korean Patent Attorney Association (1999)

Lecture of “IP Portfolio Management,” 2009 InterBiz BioPartnering Forum, Jeju, Korea (July 2009)
Lecture of “Recent Developments in US Patent law,” Korea Drug Research Association, Seoul (April, 2009)
Presentation “Technology Transfer Licensing and IP Rights Consideration,” 2008 InterBiz Biopartnering Forum, Jeju, Korea (July, 2008)
Lecture of “Examination Guideline of Obviousness in the U.S. Under KSR,” Korea Intellectual Property Office, Daejon (April, 2008)
Lecture of “Obviousness in the U.S. Under KSR,” Korea Drug Research Association, Seoul (April, 2008)
Presentation “Korea-US Free Trade Agreement,” 2007 InterBiz Biopartnering Forum, Jeju (July, 2007)
Lecture “Recent & Proposed Changes to U.S. Patent Law,” Korea Institute of Intellectual Property, Seoul (April, 2007)
Lecture of “US Market Exclusivity,” IIPRP Symposium, Delhi and Mumbai (September, 2006)
Presentation “Recent Developments in IP Law: Korea,” Association of Patent Law Firms, Chicago (September 2006) Presentation “Strategic Use of Patent Applications and Patents in Global Market Competition,” 2006 InterBiz Bioindustry Partnering, Kyungju, (July, 2006)
Lecture of “US Market Exclusivity,” Korea Drug Research Association, Seoul (April, 2006)
Presentation "Compulsory Licensing – A Comparative View: Korea,” LES 2006, Seoul (April. 2006)
Lecture of "Building a Patent Portfolio” for Daejon High-End Part Cluster, Daejon (April. 2006)
Lecture of "Merck v. Ingetra” case before the Korean Intellectual Property Office, Daejon (Feb. 2006)
Lecture of "Research Exemption under 271(e)" for Korea Patent Attorney Association, Seoul (Nov. 2005)
Lecture of “Litigation under Hatch-Waxman Act” for Korea Drug Research Association, Seoul (Feb. 2004)
Lecture of “Unique Issues on Biotech Patent Prosecution” for TechLaw 2002 Fall Meeting, Indianapolis (Oct. 2003)